Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,320.00
Ask: 2,560.00
Change: 0.00 (0.00%)
Spread: 240.00 (10.345%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
30th Jun 20164:55 pmRNSDirector/PDMR Shareholding
30th Jun 20163:58 pmRNSTotal Voting Rights
29th Jun 20164:48 pmRNSDirector/PDMR Shareholding
22nd Jun 201611:22 amRNSHolding(s) in Company
14th Jun 20167:00 amRNSChange in Reporting Segments
31st May 201611:26 amRNSTotal Voting Rights
5th May 20164:03 pmRNSResult of AGM
5th May 20163:26 pmRNSResult of AGM
5th May 20167:00 amRNSAGM Trading Update
29th Apr 20161:04 pmRNSTotal Voting Rights
18th Apr 201610:13 amRNSBlock listing Interim Review
6th Apr 20161:25 pmRNSHolding(s) in Company
6th Apr 20168:40 amRNSDirector/PDMR Shareholding
31st Mar 20161:59 pmRNSTotal Voting Rights
24th Mar 201612:02 pmRNSAnnual Financial Report
3rd Mar 20164:30 pmRNSDirector/PDMR Shareholding
1st Mar 20169:24 amRNSTotal Voting Rights
26th Feb 20161:05 pmRNSDirector/PDMR Shareholding
23rd Feb 201612:16 pmRNSDividend Timetable and Home Member State
23rd Feb 20167:00 amRNSResults for the Full Year ended 31 December 2015
29th Jan 201612:01 pmRNSTotal Voting Rights
19th Jan 20161:52 pmRNSDirector Declaration
1st Dec 20151:40 pmRNSHolding(s) in Company
1st Dec 201511:52 amRNSTotal Voting Rights
10th Nov 201510:15 amRNSHolding(s) in Company
9th Nov 201510:30 amRNSDirectorate Change
2nd Nov 20157:00 amRNSTrading Update
30th Oct 20159:40 amRNSTotal Voting Rights
19th Oct 20159:50 amRNSBlocklisting Interim Review
25th Sep 201512:38 pmRNSDirector/PDMR Shareholding
14th Sep 20155:13 pmRNSHolding(s) in Company
1st Sep 20158:54 amRNSTotal Voting Rights
24th Aug 20157:18 amRNSMorgan Sindall in JV for Thames Tideway Tunnel
5th Aug 20154:45 pmRNSDirector/PDMR Shareholding
4th Aug 20157:00 amRNSResults for the Half Year Ended 30 June 2015
21st Jul 20159:49 amRNSHolding(s) in Company
30th Jun 201512:38 pmRNSTotal Voting Rights
26th Jun 20151:01 pmRNSDirector Declaration
19th Jun 20159:10 amRNSHolding(s) in Company
29th May 20154:32 pmRNSTotal Voting Rights
19th May 201512:38 pmRNSDirector/PDMR Shareholding
13th May 20159:22 amRNSDirector/PDMR Shareholding
7th May 20151:20 pmRNSResult of AGM
7th May 20157:00 amRNSAGM Trading Update
1st May 20159:35 amRNSTotal Voting Rights
31st Mar 20159:14 amRNSTotal Voting Rights
26th Mar 20153:09 pmRNSBlocklisting Interim Review
20th Mar 20158:00 amRNSAnnual Financial Report
18th Mar 20151:47 pmRNSBlocklisting Interim Review
17th Mar 201512:49 pmRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.